Abstract
A series of substituted quinoline-5,8-diones were synthesized and evaluated as inhibitors of the chaperone protein Hsp90 using two assays: competition for binding to C-terminal ATP-binding site and competition for binding to N-terminal ATP-binding site. In addition, the ability of the compounds to induce the heat shock response was determined using a reporter fibroblast cell line. Of all the compounds assayed, only 6-aziridinyl-2-biphenylquinolinc-5,8-dione induced a heat shock response and did so without interacting at the ATP binding sites of Hsp90. COMPARE analysis was carried out on quinolinc-5,8-diones active in the National Cancer Institute's 60-cell line screen with the goal of discovering quinoline-5,8-dione structures that interact with other cellular targets (molecular targets) important for cancer chemotherapy. COMPARE analysis led to the discovery of a combretastatin-like quinoline-5,8-dione structure that, in fact, inhibited angiogenesis. © 2008 American Chemical Society.
Cite
CITATION STYLE
Hargreaves, R. H. J., David, C. L., Whitesell, L. J., LaBarbera, D. V., Jamil, A., Chapuis, J. C., & Skibo, E. B. (2008). Discovery of quinolinediones exhibiting a heat shock response and angiogenesis inhibition. Journal of Medicinal Chemistry, 51(8), 2492–2501. https://doi.org/10.1021/jm7014099
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.